Health

Amir Blatt, co-founder and previous CEO of healthtech investment firm Almeda Ventures, has joined Johnson & Johnson – Innovation, JJDC’s EMEA team.

Anja Harmeier has taken over from her previous boss to head the pharma group’s CVC.

GCV readers were drawn to stories on AI and defence as well as articles outlining how the CVC sector is changing.

Crypto-native investors such as Coinbase Ventures and Animoca Brands wrote a large number of smaller cheques while AI chipmaker Nvidia emerged as a dominant venture force, especially for large funding rounds.

Many of the new CVC units were launched by Asian corporates in Japan, China and Korea.

Marc Martin Casas, former head of Illumina Ventures Labs, has moved to the US branch of growth equity firm Premji Invest.

Alba Zurriaga will focus on digital health in her new role after four years at Sanofi Ventures.

Action Potential Venture Capital invests in bioelectronic medicines, which treat diseases with electrical pulses instead of drugs.

Olympus Innovation Ventures' second fund will invest in startups developing technology related to Olympus' endoscopy business, where it is a world leader.

Entire sub-sectors ranging from autonomous vehicles to healthcare provision to wealth management saw at least double the corporate-backed funding rounds of the same month last year.

Ronne Yeo sourced Asian life sciences startups for Johnson & Johnson's VC investment team in Singapore.